DBV Technologies (DBVT) Short term Debt (2015 - 2020)
DBV Technologies (DBVT) posted Short term Debt of $644354.2 for Q2 2020, up 0.89% sequentially from $638674.2 in Q4 2019, and little changed YoY from $642721.6 in Q3 2019.
DBV Technologies (DBVT) Short term Debt (2015 - 2020) Analysis & Trends
DBV Technologies has reported Short term Debt for 6 years, with the latest figure at $644354.2 in Q2 2020.
- Quarterly Short term Debt changed 0.25% year-over-year to $644354.2 in Q2 2020, while the trailing twelve-month figure through Jun 2020 was $644354.2 (changed 0.25% YoY) and the FY2019 annual result came in at $638674.2, down 53.41% from the prior year.
- Short term Debt climbed to $644354.2 in Q2 2020 per DBVT's latest filing, from $638674.2 in the prior quarter.
- Over five years, Short term Debt peaked at $2.7 million in Q4 2017 and troughed at $638117.0 in Q4 2016.
- A 5-year average of $1.1 million and a median of $643537.9 in 2019 frame the typical range for Short term Debt.
- The sharpest annual moves came in 2017 and 2019: Short term Debt soared 329.0% in 2017, then tumbled 53.41% in 2019.
- Over 5 years, Short term Debt stood at $638117.0 in 2016, then jumped by 329.0% to $2.7 million in 2017, then sank by 49.93% to $1.4 million in 2018, then sank by 53.41% to $638674.2 in 2019, then advanced by 0.89% to $644354.2 in 2020.
- According to Business Quant data, Short term Debt over the past three periods registered $644354.2, $638674.2, and $642721.6 for Q2 2020, Q4 2019, and Q2 2019 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | DBV Technologies | 6.08 Bn | 5.90 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | 644,354.18 |
| Dec 31, 2019 | 638,674.19 |
| Jun 30, 2019 | 642,721.56 |
| Dec 31, 2018 | 1.37 Mn |
| Dec 31, 2017 | 2.74 Mn |
| Dec 31, 2016 | 638,117.02 |
| Dec 31, 2015 | 163,321.47 |